UOC
UBS O'Connor Portfolio holdings
AUM
$1.93B
1-Year Return
38.75%
This Quarter Return
+9.04%
1 Year Return
+38.75%
3 Year Return
+182.42%
5 Year Return
+480.25%
10 Year Return
+1,573.29%
AUM
$5.59B
AUM Growth
+$865M
(+18%)
Cap. Flow
+$450M
Cap. Flow
% of AUM
8.05%
Top 10 Holdings %
Top 10 Hldgs %
66.42%
Holding
655
New
83
Increased
132
Reduced
97
Closed
122
Top Buys
| 1 |
ATVI
Activision Blizzard Inc.
ATVI
|
+$800M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$386M |
| 3 |
NEWR
New Relic, Inc.
NEWR
|
+$274M |
| 4 |
DEN
Denbury Inc.
DEN
|
+$189M |
| 5 |
VMW
VMware, Inc
VMW
|
+$172M |
Top Sells
| 1 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$230M |
| 2 |
PDCE
PDC Energy, Inc.
PDCE
|
+$221M |
| 3 |
UNVR
Univar Solutions Inc.
UNVR
|
+$219M |
| 4 |
FOCS
Focus Financial Partners Inc. Class A
FOCS
|
+$146M |
| 5 |
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
|
+$141M |
Sector Composition
| 1 | Technology | 34.96% |
| 2 | Healthcare | 28.93% |
| 3 | Real Estate | 5.18% |
| 4 | Financials | 4.45% |
| 5 | Consumer Discretionary | 4.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AGEN
251
Agenus
AGEN
$136M
| $1.63M | 0.03% |
72,204
+1,500
| +2% | +$33.9K |
|
252
Align Technology
ALGN
$9.92B
| $1.62M | 0.03% |
5,300
+409
| +8% | +$125K |
|
253
Ventyx Biosciences
VTYX
$170M
| $1.58M | 0.03% |
45,463
-13,000
| -22% | -$451K |
|
254
Alchemy Investments Acquisition Corp 1 Units
ALCYU
$133M
| $1.57M | 0.03% |
150,000
| – | – |
|
|
BCYC
255
Bicycle Therapeutics
BCYC
$485M
| $1.57M | 0.03% |
77,902
| – | – |
|
|
LADR
256
Ladder Capital
LADR
$1.5B
| $1.56M | 0.03% |
+152,300
| New | +$1.56M |
|
257
RAPT Therapeutics
RAPT
$220M
| $1.56M | 0.03% |
11,727
-375
| -3% | -$49.9K |
|
258
Asana
ASAN
$3.25B
| $1.56M | 0.03% |
85,000
+63,490
| +295% | +$1.16M |
|
259
Glaukos
GKOS
$5.27B
| $1.54M | 0.03% |
20,471
-20,000
| -49% | -$1.51M |
|
260
HilleVax
HLVX
$105M
| $1.54M | 0.03% |
114,478
+34,000
| +42% | +$457K |
|
261
89bio
ETNB
$1.27B
| $1.53M | 0.03% |
98,838
+15,000
| +18% | +$232K |
|
262
Haymaker Acquisition Corp 4
HYAC
$328M
| $1.53M | 0.03% |
+150,000
| New | +$1.53M |
|
263
Etsy
ETSY
$5.77B
| $1.52M | 0.03% |
+23,500
| New | +$1.52M |
|
264
BridgeBio Pharma
BBIO
$10.4B
| $1.51M | 0.03% |
+57,300
| New | +$1.51M |
|
265
Scholar Rock
SRRK
$3.04B
| $1.51M | 0.03% |
212,581
+10,000
| +5% | +$71K |
|
266
Insmed
INSM
$31B
| $1.5M | 0.03% |
59,292
-53,000
| -47% | -$1.34M |
|
267
Larimar Therapeutics
LRMR
$336M
| $1.5M | 0.03% |
378,505
+15,000
| +4% | +$59.3K |
|
268
Thermo Fisher Scientific
TMO
$184B
| $1.49M | 0.03% |
2,950
-5,500
| -65% | -$2.78M |
|
|
LBPH
269
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
| $1.46M | 0.03% |
262,265
| – | – |
|
270
Savara
SVRA
$665M
| $1.44M | 0.03% |
380,352
-20,000
| -5% | -$75.6K |
|
|
VRNA
271
Verona Pharma
VRNA
$9.19B
| $1.43M | 0.03% |
87,628
| – | – |
|
|
OPRA
272
Opera Ltd
OPRA
$1.73B
| $1.41M | 0.03% |
+125,000
| New | +$1.41M |
|
273
Incyte
INCY
$16.9B
| $1.41M | 0.03% |
24,349
-32,000
| -57% | -$1.85M |
|
274
Orthofix Medical
OFIX
$581M
| $1.39M | 0.02% |
108,032
+40,000
| +59% | +$514K |
|
275
ADT
ADT
$7.07B
| $1.38M | 0.02% |
229,607
| – | – |
|